A clearer way to review prior authorization cases.

METHUVIA AI - PRODUCT WALKTHROUGH V3.2 Narration transcript ============================================================== Prior authorization review often begins with clinical information spread across multiple documents. Methuvia brings that information into a structured clinical review workflow. Its interoperability layer is designed to receive clinical information through controlled external intake pathways while preserving the same review and safety boundaries inside Methuvia. In this fully synthetic case, the prior authorization request, chart notes, and coverage policy are available together for review. Methuvia organizes the submitted documentation and keeps the original source material available to the reviewer. The applicable policy requirements are evaluated individually, with supporting clinical evidence connected to each requirement. That evidence remains traceable to its source and page, so the reviewer can inspect where the information came from rather than relying on an unsupported conclusion. When the record does not establish a requirement, Methuvia does not fill in the gap. Here, the methotrexate dose and inadequate response are documented, but the required treatment duration is not. Methuvia therefore prepares an advisory recommendation to request more information. That recommendation is not the coverage decision. The pharmacist reviews the evidence and remains responsible for the final determination. AI prepares the review. Pharmacists make the decision.